Spironolactone Tablet, Coated
Product Images NDC 76420-925

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 76420-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg (100mg)

Six packaging labels for Spironolactone Tablets USP 100 mg from Enovachem Pharmaceuticals, relabeled or packaged by them, with quantities of 100, 500, 1000, 30, 60, and 90 tablets. Each label displays the product name, strength, NDC numbers, barcodes, and manufacturer listed as Oxford Pharmaceuticals, LLC. Labels include warnings about prescription dispensing and storage instructions.*

FDA Label Image

25 mg Label (25mg)

Multiple packaging labels for Spironolactone Tablets, USP 25 mg, from Enovachem Pharmaceuticals. Each label displays different package quantities, including 30, 60, 90, 100, 500, 1000, and 2500 tablets. Labels show NDC codes, manufacturer Oxford Pharmaceuticals LLC, product descriptions, and storage caution statements.*

FDA Label Image

50 mg Label (50mg)

Label sheets for Spironolactone Tablets USP 50 mg by Enovachem Pharmaceuticals, relabeled by the same, packaged by Oxford Pharmaceuticals, LLC. Labels display NDC codes, package counts ranging from 30 to 1000 tablets, barcodes, storage instructions, and a cautionary federal law statement. Tablets are described as oval, white to off-white, coated and debossed.*

FDA Label Image

Figure 1 (Figure1)

A Kaplan-Meier survival curve comparing the probability of survival over time in months between two groups: one treated with Spironolactone and a placebo group. The graph shows a higher survival probability for the Spironolactone group with statistical significance (log-rank p < 0.001).*

FDA Label Image

Figure 2 (Figure2)

A forest plot chart presenting hazard ratios (HR) and 95% confidence intervals (CI) comparing Spironolactone versus placebo across various subgroups. Subgroups include age ranges, sex, race, left ventricular ejection fraction (LVEF) levels, heart failure type, NYHA classification, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot visually indicates whether Spironolactone or placebo is favored in each subgroup.*

FDA Label Image

20 (Spironolactone Tablets Usp 1)

Chemical structure of spironolactone, a steroidal compound with characteristic ring structures and functional groups including a lactone and thioacetyl moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.